Vico Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Vico Therapeutics's estimated annual revenue is currently $9.2M per year.
- Vico Therapeutics's estimated revenue per employee is $210,136
Employee Data
- Vico Therapeutics has 44 Employees.
- Vico Therapeutics grew their employee count by 19% last year.
Vico Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific Officer & Site Head | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Lead Clinical Project Manager | Reveal Email/Phone |
5 | Manufacturing chemist | Reveal Email/Phone |
6 | Senior Scientist | Reveal Email/Phone |
7 | Scientist PK & assay development | Reveal Email/Phone |
8 | Research Technician Molecular Biology | Reveal Email/Phone |
9 | Molecular analyst | Reveal Email/Phone |
10 | Senior Scientist | Reveal Email/Phone |
Vico Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 221 | 16% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 91 | -10% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 16 | -6% | $114.3M | N/A |
#8 | $7.2M | 28 | -7% | N/A | N/A |
#9 | $13.7M | 51 | -9% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Vico Therapeutics?
Bringing knowledge, experience and science together to discover, develop and deliver therapies for CNS disorders. Vico was founded in Q4 2019 by the highly experienced entrepreneurs Luc Dochez and Josh Mandel-Brehm and seasoned scientists Dr. Judith van Deutekom and Dr. Gail Mandel with strong academic reputations and vast industry experience. Together with a team of skilled scientists and drug development professionals, Vico's focus is on development of RNA modulating therapies for rare neurological disorders, with initial focus on SCA – Spinocerebellar ataxia, HD – Huntington's disease and RETT syndrome.
keywords:N/A
N/A
Total Funding
44
Number of Employees
$9.2M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vico Therapeutics News
Alex Therapeutics develops software as a medical device (SaMD) ... The company's shares (VICO) are listed on Nasdaq Stockholm's main market.
Other Companies in Leiden
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.4M | 44 | 2% | N/A |
#2 | $12.9M | 53 | -5% | N/A |
#3 | $16M | 60 | 2% | N/A |
#4 | N/A | 61 | 20% | N/A |
#5 | $10.1M | 65 | 35% | N/A |